The standard treatment for peritoneal mesothelioma patients eligible for
surgery is cytoreductive surgery (CRS) followed immediately by heated intraperitoneal
Traditional surgery involves a large incision made in the abdomen in order
to remove as much cancer as possible. A
study published in the European Journal of Surgical Oncology shows that patients
suffering from peritoneal surface malignancy from mesothelioma and other
cancers may benefit from less invasive laparoscopic surgical procedures.
Laparoscopic procedures require a much smaller incision than traditional
surgery and utilize a fiber optic camera so that surgeons may perform
the procedure viewing a monitor.
Researchers at the Hospices Civils de Lyon in France compared two groups
of patients who underwent CRS followed by HIPEC. Patients in the first
group underwent the laparoscopic CRS procedure and experienced far fewer
complications and spent an average of a week less in the hospital than
those in the second group who underwent the more traditional CRS procedures.
Another benefit of the laparoscopic approach is reduced pain due to smaller
incision and less hemorrhaging. All participants in the study were diagnosed
with early stage disease which had not spread beyond the peritoneum.
Fewer complications, shorter recovery time and reduced pain all contribute
to better quality of life, which is of great value to any cancer or surgical
patient. Many hospitals and surgical centers now offer the minimally invasive
laparoscopic procedure for a wide range of ailments. Peritoneal mesothelioma
patients should speak to their surgeon to find out if laparoscopic surgery
is an option for them.